Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 2, 2014

View Archived Issues

Improving T1D diagnosis using a novel plasmonic gold chip-based sensor

Validation of a multi-component serum biomarker for the diagnosis of EAC

Canadian and U.S. group discloses new RNA oligomers

Celgene patents novel ERK inhibitors

Pneumococcal vaccines prepared at the Children's Medical Center

Novel Hdm2 inhibitors for cancer disclosed by Merck & Co.

Japanese authorities grant additional approval for Victoza in combination with other agents

WIN-1001X herbal extract shows promise in animal models of PD

Pfizer Japan receives additional indication approval for Solu-Medrol

Merck & Co. prepares novel HCV NS5B inhibitors

Ipsen confirms U.S. and E.U. acceptance of filings for Somatuline

Plethora Solutions to license rights to PSD-502 to European partner

GSK's Lamictal approved as monotherapy for epilepsy in Japan

Ablynx signs license agreement with Eddingpharm to develop ozoralizumab

Russian Ebola vaccine shows promise in preclinical studies

African ginger extract improves symptomatology of asthma and allergies in vivo

Exelixis reports topline results from COMET-1 study of cabozantinib

Novo Nordisk to discontinue R&D activities for inflammatory disorders

ReNeuron offers pipeline update

ValiSeek advances VAL-401 through preclinical testing

ZMapp effectiveness as Ebola therapeutic established in NHP

Birken reports results from phase III trials of Oleogel-S10 for partial thickness wounds

Metgluco additional dosage approved for pediatric type 2 diabetes in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...